Mufg Americas Holdings Corp Abbott Laboratories Transaction History

Mufg Americas Holdings Corp

  • $0
  • Q3 2023

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Dec 01, 2022
SELL
$96.76 - $112.03 $506,345 - $586,252
-5,233 Reduced 2.05%
250,252 $24.2 Million
Q3 2022

Oct 31, 2022
SELL
$96.76 - $112.03 $506,345 - $586,252
-5,233 Reduced 2.05%
250,252 $24.2 Million
Q2 2022

Dec 01, 2022
SELL
$102.07 - $123.37 $367,247 - $443,885
-3,598 Reduced 1.39%
255,485 $27.8 Million
Q2 2022

Aug 02, 2022
SELL
$102.07 - $123.37 $367,247 - $443,885
-3,598 Reduced 1.39%
255,485 $27.8 Million
Q1 2022

Dec 01, 2022
SELL
$114.02 - $139.04 $324,272 - $395,429
-2,844 Reduced 1.09%
259,083 $30.7 Million
Q1 2022

May 06, 2022
SELL
$114.02 - $139.04 $324,272 - $395,429
-2,844 Reduced 1.09%
259,083 $30.7 Million
Q4 2021

Dec 01, 2022
SELL
$115.53 - $141.46 $237,067 - $290,275
-2,052 Reduced 0.78%
261,927 $36.9 Million
Q4 2021

Feb 09, 2022
SELL
$115.53 - $141.46 $237,067 - $290,275
-2,052 Reduced 0.78%
261,927 $36.9 Million
Q3 2021

Dec 01, 2022
SELL
$116.66 - $129.06 $649,212 - $718,218
-5,565 Reduced 2.06%
263,979 $31.2 Million
Q3 2021

Nov 05, 2021
SELL
$116.66 - $129.06 $649,212 - $718,218
-5,565 Reduced 2.06%
263,979 $31.2 Million
Q2 2021

Dec 01, 2022
SELL
$105.79 - $124.53 $1.08 Million - $1.28 Million
-10,242 Reduced 3.66%
269,544 $31.2 Million
Q2 2021

Aug 06, 2021
SELL
$105.79 - $124.53 $1.08 Million - $1.28 Million
-10,242 Reduced 3.66%
269,544 $31.2 Million
Q1 2021

Dec 01, 2022
SELL
$108.84 - $128.23 $5.25 Million - $6.19 Million
-48,238 Reduced 14.71%
279,786 $33.5 Million
Q1 2021

Apr 30, 2021
SELL
$108.84 - $128.23 $5.25 Million - $6.19 Million
-48,238 Reduced 14.71%
279,786 $33.5 Million
Q4 2020

Dec 01, 2022
SELL
$105.0 - $114.42 $837,165 - $912,270
-7,973 Reduced 2.37%
328,024 $35.9 Million
Q4 2020

Feb 03, 2021
SELL
$105.0 - $114.42 $837,165 - $912,270
-7,973 Reduced 2.37%
328,024 $35.9 Million
Q3 2020

Dec 01, 2022
SELL
$91.64 - $111.29 $676,761 - $821,876
-7,385 Reduced 2.15%
335,997 $36.6 Million
Q3 2020

Nov 03, 2020
SELL
$91.64 - $111.29 $676,761 - $821,876
-7,385 Reduced 2.15%
335,997 $36.6 Million
Q2 2020

Dec 01, 2022
BUY
$76.57 - $98.0 $7.13 Million - $9.13 Million
93,130 Added 37.21%
343,382 $31.4 Million
Q2 2020

Aug 06, 2020
SELL
$76.57 - $98.0 $759,114 - $971,572
-9,914 Reduced 2.81%
343,382 $31.4 Million
Q1 2020

Apr 24, 2020
SELL
$62.82 - $91.86 $878,914 - $1.29 Million
-13,991 Reduced 3.81%
353,296 $27.9 Million
Q4 2019

Feb 10, 2020
SELL
$78.51 - $87.4 $974,544 - $1.08 Million
-12,413 Reduced 3.27%
367,287 $31.9 Million
Q3 2019

Nov 06, 2019
BUY
$81.84 - $88.74 $1.07 Million - $1.16 Million
13,029 Added 3.55%
379,700 $31.8 Million
Q2 2019

Aug 09, 2019
BUY
$72.88 - $85.0 $177,972 - $207,570
2,442 Added 0.67%
366,671 $30.8 Million
Q1 2019

May 13, 2019
SELL
$66.22 - $80.06 $54,565 - $65,969
-824 Reduced 0.23%
364,229 $29.1 Million
Q4 2018

Feb 13, 2019
BUY
$65.56 - $74.27 $537,854 - $609,311
8,204 Added 2.3%
365,053 $26.4 Million
Q3 2018

Nov 14, 2018
BUY
$60.81 - $73.36 $1.3 Million - $1.57 Million
21,341 Added 6.36%
356,849 $0
Q2 2018

Aug 10, 2018
BUY
$57.57 - $63.54 $85,491 - $94,356
1,485 Added 0.44%
335,508 $0
Q1 2018

May 07, 2018
SELL
$56.27 - $63.62 $536,253 - $606,298
-9,530 Reduced 2.77%
334,023 $20 Million
Q4 2017

Feb 08, 2018
BUY
$53.68 - $57.47 $303,882 - $325,337
5,661 Added 1.68%
343,553 $0
Q3 2017

Nov 13, 2017
SELL
$48.06 - $53.64 $201,083 - $224,429
-4,184 Reduced 1.22%
337,892 $0
Q2 2017

Aug 07, 2017
BUY
N/A
342,076
342,076 $0

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mufg Americas Holdings Corp Portfolio

Follow Mufg Americas Holdings Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email